Cargando…
The Emergency Response Capacity of Plant-Based Biopharmaceutical Manufacturing-What It Is and What It Could Be
Several epidemic and pandemic diseases have emerged over the last 20 years with increasing reach and severity. The current COVID-19 pandemic has affected most of the world’s population, causing millions of infections, hundreds of thousands of deaths, and economic disruption on a vast scale. The incr...
Autores principales: | Tusé, Daniel, Nandi, Somen, McDonald, Karen A., Buyel, Johannes Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606873/ https://www.ncbi.nlm.nih.gov/pubmed/33193552 http://dx.doi.org/10.3389/fpls.2020.594019 |
Ejemplares similares
-
Technoeconomic Modeling of Plant-Based Griffithsin Manufacturing
por: Alam, Aatif, et al.
Publicado: (2018) -
Techno‐economic analysis of a plant‐based platform for manufacturing antimicrobial proteins for food safety
por: McNulty, Matthew J., et al.
Publicado: (2019) -
Editorial: Plant-Production Platforms for Veterinary Biopharmaceuticals
por: Baschieri, Selene, et al.
Publicado: (2022) -
Manufacturing Economics of Plant-Made Biologics: Case Studies in Therapeutic and Industrial Enzymes
por: Tusé, Daniel, et al.
Publicado: (2014) -
Plant Molecular Farming – Integration and Exploitation of Side Streams to Achieve Sustainable Biomanufacturing
por: Buyel, Johannes F.
Publicado: (2019)